| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5725341 | Revue des Maladies Respiratoires Actualités | 2016 | 11 Pages |
Abstract
Emesis, anemia and neutropenia have an impact on quality of life of patients suffering from lung cancer. They may induce a dose reduction of specific treatments and decrease their related efficacy. Although usually related to historical chemotherapy, these toxicities may develop with new therapies like targeted treatments or immunotherapy. A review has been performed in order to update the management of these toxicities. Supportive care and supportive treatments involvement have a key role in quality of management of lung cancer patients
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
F. Scotté, S. Morin, A. Saadi, C. Brahmi,